Treat Sleep Apnea, Lower Your Medical Spend

Impact of OSA Therapy on Healthcare Costs PDF - Click Here to Download

Research studying the economics of Obstructive Sleep Apnea (OSA) therapy faces confounds including the prevalence of undiagnosed OSA, rate of diagnosed patients not starting continuous positive airway pressure (CPAP) therapy, spectrum of CPAP treatment adherence, and effects of concurrent comorbidity.

We provide an actuarial analysis to study the economic impact of OSA therapy using CPAP, accounting for these confounds, using the 2016-2018 Medicare 5% Limited Data Set (LDS) Analytical File, a random sample of Medicare Claims containing approximately 2.9 million patients/year, resulting in N=2,001,538 eligible Fee-For-Service patients excluding managed care patients and incomplete data.